Polysaccharides are complex carbohydrates composed of repeated sugar units linked by glycosidic bonds, and they serve as a versatile source for developing biomaterials. Polysaccharide-based biomaterials have gained prominence in various biomedical applications due to their biocompatibility, biodegradability, and diverse functionalities. Natural polysaccharides such as cellulose, chitosan, alginate, and hyaluronic acid are commonly used in biomaterial research. These materials offer a wide range of properties, making them suitable for applications in drug delivery, tissue engineering, wound healing, and regenerative medicine. Polysaccharide-based biomaterials can be tailored to exhibit specific physical and chemical characteristics, allowing researchers to modulate their mechanical strength, degradation rates, and bioactive functionalities for targeted applications. The hydrophilic nature of many polysaccharides promotes water absorption, making them suitable for hydrogel formulations. Hydrogel-based biomaterials are particularly useful in tissue engineering for mimicking the extracellular matrix and supporting cell growth. Polysaccharide-based nanoparticles have been explored for drug delivery systems, providing a stable platform for controlled release and targeted delivery of therapeutic agents. These nanoparticles can be designed to respond to specific stimuli, enhancing their precision in drug delivery. The immunomodulatory properties of certain polysaccharides, such as β-glucans, have been investigated for applications in immunotherapy and vaccine development. Polysaccharide-based materials can stimulate immune responses, making them valuable in enhancing the efficacy of vaccines.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States